A screening library for peptide activated G-protein coupled receptors. 1. The test set

Journal of Medicinal Chemistry

Volumn 47, Issue 27, 2004, Pages 6864-6874

  Lavrador, Karine ^a   Murphy, Brian ^b   Saunders, John ^a   Struthers, Scott ^b   Wang, Xiaochuan ^a   Williams, John ^a  

^a Chemistry Department   (United States)

^b Biology Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GALANIN RECEPTOR; GONADORELIN RECEPTOR; LIGAND; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR; MELANOCORTIN RECEPTOR; OREXIN; OREXIN RECEPTOR; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; DNA SCREENING; EATING DISORDER; EVALUATION; GENITAL SYSTEM DISEASE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; NARCOLEPSY; NONHUMAN; OBESITY; PAIN; PEPTIDE ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; RANDOMIZATION; RAT; SURFACE CHARGE;

ANIMALS; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; PEPTIDE LIBRARY; PEPTIDES; RATS; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 11144237578     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040084c     Document Type: Article

References (20)

1. The most up to date listing can be viewed and searched on the GPCRDB home page at http://www.darmstadt.gmd.de/~gpcrdb.
2. Watson, S.; Arkinstall, S. The G-Protein Linked Receptor Facts-Book; Academic Press: San Diego, CA, 1996.
3. For a list of the Top 200 Prescription Medicines see: http://www.rxlist.com/top200.htm.
4. Marshall, G. R. Peptide Interactions with G-Protein Coupled Receptors. Biopolymers (Pept. Sci.) 2001, 60, 246-277.
5. Rees, D. C. Non-Peptide Ligands for Neuropeptide Receptors. Anna. Rep. Med. Chem. 1993, 28, 59-68.
6. Sugg, E. E. Non-peptide Agonists for Peptide Receptors: Lessons from Ligands. Anna. Rep. Med Chem. 1997, 32, 277.
7. Yang, L. Non-Peptide Somatostatin Receptor Ligands. Anna. Rep. Med. Chem. 1999, 34, 209-218.
8. Pearlman, R. S.; Smith, K M. Novel Software Tools for Chemical Diversity. Perspect. Drug Discovery 1998, 9, 339-353.
9. Pearlman, R. S.; Smith, K. M. Metric Validation and the Receptor-Relevant Subspace Concept. J. Chem. Inf. Comput. Sci. 1999, 39, 28-35.
10. Williams, J. P.; Lavrador, K. A Solution-Phase Combinatorial Synthesis of Selective Dopamine D4 Ligands. Comb. Chem. HTS 2000, 3, 43-50.
11. Zeng, L.; Burton, L.; Yung, K.; Shushan, B.; Kassel, D. B. Automated Analytical/Preparative High-Performance Liquid Chromatography-Mass Spectrometry System for the Rapid Characterization and Purification of Compound Libraries. J. Chromatogr. A 1998, 794, 3-13.
12. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures. J. Org. Chem. 1996, 61, 3849-3862.
13. Cone, R. D.; Lu, D.; Koppula, S.; Vage, D. I.; Klungland, H.; Boston, B.; Chen, W.; Orth, D. N.; Pouton, C.; Kesterson, R. A. The Melanocortin Receptors: Agonists, Antagonists, and the Hormonal Control of Pigmentation. Rec. Prog. Hor. Res. 1996, 51, 287-318.
14. Goodfellow, V. S.; Saunders, J. The Melanocortin System and Its Role in Obesity and Cachexia. Curr. Top. Med. Chem. 2003, 3, 855-883.
15. Qu, D.; Ludwig, D. S.; Gammeltoft, S.; Piper, M.; Pelleymounter, M. A.; Cullen, M. J.; Mathes, W. F.; Przypek, J.; Kanarek, R.; Maratos-Flier, E. A Role For Melanin-Concentrating Hormone in the Central Regulation of Feeding Behavior. Nature 1996, 380, 243-7.
16. Borowsky, B.; Durkin, M. M.; Ogozalek, K.; Marzabadi, M. R.; DeLeon, J.; Lagu, B.; Heurich, R.; Lichtblau, H.; Shaposhnik, Z.; Daniewska, I.; Blackburn, T. P.; Branchek, T. A.; Gerald, C.; Vaysse, P. J.; Forray, C. Antidepressant, Anxiolytic and Anorectic Effects of a Melanin-Concentrating Hormone-1 Receptor Antagonist. Nat. Med. 2002, 8, 825-30.
17. Sealfon, S. C.; Weinstein, H.; Millar, R. P. Molecular Mechanisms of Ligand Interaction with the Gonadotropin-Releasing Hormone Receptor. Endocr. Rev. 1997, 18, 180-205.
18. Emons, G.; Grundker, C.; Gunthert, A. R.; Westphalen, S.; Kavanagh, J.; Versschraege, C. GnRH Antagonists in the Treatment of Gynaecological and Breast Cancers. Endocr. Relat. Cancer 2003, 10, 291-299.
19. Zhang, J.-H.; Chung, T. D. Y.; Oldenburg, K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screening 1999, 4, 67-73.
20. Ohmori, J.; Maeno, K.; Hidaka, K.; Nakato, K.; Matsumoto, M.; Tada, S.; Hattori, H.; Sakamoto, S.; Tsukamoto, S. Dopamine D3 and D4 receptors Antagonists: Synthesis and Structure-Activity Relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4-[(cyclopropylcarbonyl)amino] -2-methoxybenzamide(YM-43611) and related compounds. J. Med. Chem. 1996, 39, 2764-2772.